Method and system for determining levels of gases

ABSTRACT

A method and system for measuring or assessing the homeostatic relationship between gases in the body, environment or water. The measured or assessed level of gases in the body, environment or air uses the interrelationships of the various components in order to establish guidelines for treating individuals, the environment or water.

This patent application is a continuation of U.S. application Ser. No.13/013,374, filed Jan. 25, 2011, which claims the benefit of U.S.Provisional Application Ser. No. 61/334,642, filed May 25, 2010, thecontents of each of which are incorporated herein by reference in theirentirety.

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates to the field of measuring the levels ofgases in the body of individuals or the environment for treatment.

2. Description of the Related Technology

All forms of life are supported by a variety of substances; includingbut not limited to hormones, proteins, peptides, amino acids, minerals(ions), vitamins (chemicals or compounds that function as vitamins) andbacteria. These substances create the homeostasis essential to maintainlife for humans as well as plants and animals.

Current scientific findings have not identified that some pairs ofsubstances affect levels of each other in the body. Furthermore, certainother substances modulate (regulate) levels of the pairs of substances.Additionally, certain substances are a part of more than one modulatedpair of substances. These relationships can be utilized in order todetermine various health parameters of an individual, however, to date;these corollary relationships have not been established in order toeffectively use them.

Therefore, there is a need in the field to identify and utilize thehomeostatic relationship between the substances that are important tothe body's functioning via the measuring of various levels of thesubstances that are part of these pairings. There is also a need toutilize the homeostatic relationships in order to analyze differentenvironments.

SUMMARY OF THE INVENTION

An object of the invention is the establishing of a treatment based upongases in the body.

Another object of the invention is remediation of imbalances inrelationships between gases in the body.

Still yet another object of the invention of the invention is theestablishing of a treatment based upon gases in an environment.

Another object of the invention is remediation of imbalances inrelationships between gases in an environment.

Still yet another object of the invention of the invention is theestablishing of a treatment based upon gases in water.

Another object of the invention is remediation of imbalances inrelationships between gases in water.

An aspect of the present invention may be a method for treating anindividual by comparing levels of gases in an individual: measuring alevel of nitric oxide in the individual; measuring a level of carbonmonoxide in the individual; measuring a level of hydrogen sulfide in theindividual; comparing the measured levels; and establishing a treatmentbased upon the compared measured levels.

Another aspect of the present invention may be a method for establishinga treatment by comparing levels of gases in an environment: measuring alevel of nitric oxide in the environment; measuring a level of carbonmonoxide in the environment; measuring a level of hydrogen sulfide inthe environment; comparing the measured levels; and establishing atreatment based upon the compared measured levels.

Still yet another aspect of the present invention may be a method forestablishing a treatment by comparing levels of gases in water;measuring a level of nitric oxide in the water; measuring a level ofcarbon monoxide in the water; measuring a level of hydrogen sulfide inthe water; comparing the measured levels; and establishing a diagnosisbased upon the compared measured levels.

These and various other advantages and features of novelty thatcharacterize the invention are pointed out with particularity in theclaims annexed hereto and forming a part hereof. However, for a betterunderstanding of the invention, its advantages, and the objects obtainedby its use, reference should be made to the drawings which form afurther part hereof, and to the accompanying descriptive matter, inwhich there is illustrated and described a preferred embodiment of theinvention.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates the relationship of a modulated pair.

FIG. 2 shows the relationship between nitric oxide and carbon monoxidemodulated by hydrogen sulfide.

FIG. 3 shows the relationship between oxygen and carbon dioxidemodulated by nitric oxide.

FIG. 4 shows the relationship between nitric oxide and carbon monoxidemodulated by hydrogen sulfide and nitric oxide modulating oxygen andcarbon dioxide.

FIG. 5 shows the method of measuring levels of nitric oxide, carbonmonoxide and hydrogen sulfide within an individual, in accordance withan embodiment of the present invention.

FIG. 6 shows the method of measuring levels of oxygen, carbon dioxideand nitric oxide within an individual, in accordance with an embodimentof the present invention.

FIG. 7 is a schematic diagram showing the system for measuring thelevels of gases contained within the body.

FIG. 8 is a flow chart showing the steps involved in using the systemshown in FIG. 7.

FIG. 9 is a schematic diagram showing the system for measuring thelevels of gases contained within the atmosphere or environment.

FIG. 10 is a flow chart showing the steps involved in using the systemshown in FIG. 9.

FIG. 11 is a schematic diagram showing the system measuring the levelsof gases within water.

FIG. 12 is a flow chart showing the steps involved in using the systemshown in FIG. 11.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT(S)

All forms of life are supported by modulated pairs of substances. Thesesubstances create the homeostasis essential to maintain life for humansas well as animals.

Several terms are used herein and are defined as follows:

The term “modulator” means an agent, substance or mechanism thatfacilitates the maintenance of homeostasis between pairs. “Pairs” may behormones, minerals, proteins, amino acids, bacteria, virus, gases andnatural processes. The agent can decrease intensity of stimulatoryprocesses or substances, or increase intensity of compensatory ones.

The term “catalyst” means the driver which initiates modulation to takeplace. Such catalysts can include enzymes, hormones, RNA, gases andcountless signaling mechanisms.

The term “gas” refers to all compounds and molecules that aredistinguished from the solid and liquid states by relatively low densityand viscosity and relatively great expansion.

The term “Homeostatic Relationship (Homeostasis)” means the balance orequilibrium between two substances. The relationship does not have to be50%-50% but can vary depending upon the two substances in question.

The term “Extracellular Matter (ECM)” means all body fluid outside ofcells and blood; including but not limited to cerebrospinal fluid,lymph, chyle, interstitial fluid, saliva, transcellular fluid, amnioticfluid, sperm, and sputum.

The term “Mental Functioning Activity (MFA)” means the rate of activityattributable to the neural firing rate in the brain and elsewhere in thebody.

The invention addresses the diagnostic analysis of the corollaryrelationships between gases that provide and maintain homeostasis in anindividual as well as within the environment.

The data for measuring homeostasis between gases within a modulated paircan vary from one individual or specimen to another due to environmentalfactors, basic metabolism, genetic make-up and other factors.Accordingly, a range of homeostatic relationships will need to bedetermined for all modulated pairs in order to assess deviations anddisruptions.

By utilizing the analysis of data relative to the ranges of homeostasisand the deviations thereof, medical science (for humans as well as wellas in veterinary medicine for animals) will be able to manufacture newpharmaceutical products and other substances, prepare diets, manufacturedevices, create therapies, compound personalized nutrients or substancesof various types in order to maintain or regulate homeostasis.

Data derived from the application of the invention will allow fordiagnostic analysis and control of levels of gases in order to preventtheir depletion, to maintain adequate levels to prevent disruption aswell as to create recommendations for which substances may counteractwith others and the levels of which substances must be modified on anongoing basis in order to provide optimal health/well being throughhomeostasis.

Since nutrients, such as vitamins, minerals, electrolytes, enzymes,amino acids, proteins, etc., are essential to create defenses for theorgans, glands and operating systems of the body, as well as to providethe energy to sustain life, establishing corollary relationships betweengases that may require “nutrients” for their production will enablecross-category analysis to prevent depletion of the body's defense inorder to prevent illness as well as to increase levels of nutritionalenergy to strengthen the body to offset the effects of existing ailmentsand diseases.

The concept of modulation in relation to homeostatic pairs isillustrated in FIG. 1. This example illustrates a relationship betweentwo substances, A and B, and the existence of a third substance C thatserves to support A or B in order to attempt to maintain an adequatelevel of homeostasis (balance) between the two substances.

Some examples of modulated pairs in gases within an individual include,nitric oxide and carbon dioxide modulated by hydrogen sulfide and oxygenand carbon monoxide modulated by nitric oxide.

It should be noted that some gases can function as part of a pair andalso be a modulator for another pair. For example, noted above was thepair of nitric oxide and carbon monoxide, which is modulated by hydrogensulfide. Nitric oxide also operates as a modulator for the pair ofoxygen and carbon dioxide.

Correlation between base values expressed when the range of homeostasisis determined and individual test results can be used as a means ofassessing levels or disruptions between pairs or the existence ofincreases in the levels of modulators in order to maintain homeostasis.Methods of diagnostic analysis may also detect the presence of catalystsas markers for the existence of a disruption within a modulated pairthat the body is in the process of correcting. Detection of suchcatalysts may be included as a factor in the process of analyzing thecorrelation of substances within modulated pairs.

Described herein is an example of the determination of homeostaticlevels of the sets of modulated pairs discussed above. The first set isthe pair of nitric oxide 10 and carbon monoxide 12 which is modulated byhydrogen sulfide 14 and the pair of oxygen 16 and carbon dioxide 18modulated by nitric oxide 10. These relationships are shown in FIGS.2-4. It can be seen from FIG. 4 how nitric oxide 10 is both modulatedand a modulator. As such the five gases are interconnected and theirinterrelationship plays a role in the functioning of an individual'shealth processes.

FIG. 5 shows the method of evaluating the homeostatic levels of one setof the modulated pairs in order to provide a base index foradministering medication and performing analysis. In step 102 the levelof nitric oxide 10 is measured in an individual. The level of nitricoxide 10 may be measured by a variety of diagnostic tests that includebut are not limited to the analysis of diagnostic imaging that indicatesactivity and the analysis of various fluids, excretions and exhalations,within and produced by the body. Examples of these fluids and excretionsinclude: blood and its components; serum; urine; fecal matter; collagen;chyle; interstitial fluid (tissue fluid); lymph; extracellular fluid;amniotic fluid; sweat tears; saliva; mucus; phlegm; hair; fingernails;bone marrow and exhaled breath.

In addition to the conventional diagnostic analysis of levels ofsubstances from the aforementioned sources, various existing and yet tobe developed diagnostic processes that measure outcomes resulting fromthese substances can be utilized. These devices may include blood gasanalysis devices, devices to assess levels of gases exhaled fromindividuals, EEG, PET scans, use of MEG machines, SPECT analysis,functional and diffusion MRI technologies as well as other iterationsthereof (fMRI and dMRI respectively), CT scans, and ultrasound.Correlation between base values expressed when the range of homeostasisis determined and individual test results may then be used as a means ofassessing levels or disruptions between pairs or the existence ofincreases in the levels of modulators in order to maintain homeostasis.Methods of diagnostic analysis may also detect the presence of catalystsas markers for the existence of a disruption within a modulated pairthat the body is in the process of remediating. Detection of suchcatalysts is included as a factor in the process of analyzing thecorrelation of substances within modulated pairs.

This invention provides the biological foundation that will enablemonitoring relationships within modulated pairs of substances as theyrelate to medical care; including wellness, prevention and treatmentpertaining to the mind (brain) and body as well as environmental issues;e.g. the quality of air and water.

The measured level of nitric oxide 10 in the body or environment may beexpressed in various units depending upon the test employed in order tomeasure the level of the nitric oxide 10. This level can be expressed bythe variable X. There is a preferred range in which X may fall thatvaries depending upon the type of test that is used in order to measurethe level of nitric oxide 10. In an embodiment of the present inventiona standard type of test is used.

In step 104 the level of carbon monoxide 12 in an individual ismeasured. This level can be measured using one of the various processeslisted above. The measured level of carbon monoxide 12 is preferablyexpressed in the same units of measurement as that used in themeasurement of nitric oxide 10 so as to more readily compare the levelswith respect to each other in order to obtain a base level. This levelcan be expressed by the variable Y. There is a preferred range in whichY may fall that varies depending upon the type of test that is used inorder to measure the level of carbon monoxide 12. In an embodiment ofthe present invention a standard type of test is used.

In step 106 the level of hydrogen sulfide 14 in an individual ismeasured. This level can be measured using one of the processes listedabove. The measured level of hydrogen sulfide 14 is preferably expressedin the same units of measurement as that used in the measurement ofnitric oxide 10 so as to more readily compare the levels with respect toeach other in order to obtain a base level. This level can be expressedby the variable Z. There is a preferred range in which Z may fall thatvaries depending upon the type of test that is used in order to measurethe level of hydrogen sulfide 14. In an embodiment of the presentinvention a standard type of test is used.

In step 108, the measured levels X, Y and Z are then compared tostandard levels. This may be done in a number of different ways. Onepossible way in which this can be accomplished is to total the values ofall of the levels (X+Y+Z) in order to establish sum level C. This sumlevel C can be used in step 110 in order to establish an appropriatetreatment of the individual that may include the provision of medicationand other matters related to the measured levels. Another method is tocompare the ratios of X:Y, X:Z and Y:Z to determine whether or not theproper ratio levels are maintained and/or present. These ratio levelsmay then be used in providing an appropriate treatment.

The treatment may include, but is not limited to the provision of morehydrogen sulfide 14 to an individual. Alternatively, the reduction ofhydrogen sulfide 14 may be necessitated. The provision of and/orreduction of carbon monoxide 12 and/or nitric oxide 10 may also be partof the treatment in order to return the levels of nitric oxide 10,carbon monoxide 12 and hydrogen sulfide 14 to normal levels.

An example of this is provided below using hypothetical numbers so as tomake understanding of the process easier.

Measuring nitric oxide 10 via a blood test results in a number for Xthat results in a number 5, from within a range of 1-10. Measuringcarbon monoxide 12 via a blood test results in a number for Y of 4 fromwithin a range of 1-10. Measuring hydrogen sulfide 14 via a blood testresults in a number for Z of 6 from within a range of between 1-10.These numbers are then totaled and results in a C value of 15. A valuefor C between 10 and 20 may indicate a normal level.

The method of evaluating the homeostatic levels of the pair of oxygen 16and carbon dioxide 18 modulated by nitric oxide 10 may be used in orderto provide a base index for administering medication and to performbehavioral analysis. This method is shown in FIG. 6. In step 202 thelevel of oxygen 16 is measured in an individual. The level of oxygen 16may be measured by a variety of diagnostic tests similar to thatdiscussed above that include but are not limited to the analysis ofdiagnostic imaging that indicates activity and the analysis of variousfluids and excretions within and produced by the body. Examples of thesefluids and excretions include: blood and its components, serum; urine;fecal matter; collagen; chyle; interstitial fluid (tissue fluid); lymph;extracellular fluid; amniotic fluid; sweat tears; saliva; mucus; phlegm;hair; fingernails; bone marrow. The measured level of oxygen 16 in thebody is expressed in various units depending upon the test employed inorder to measure the level of the oxygen 16. This level can be expressedby the variable X. There is a preferred range in which X may fall thatvaries depending upon the type of test that is used in order to measurethe level of oxygen 16. In an embodiment of the present invention astandard type of test is used.

In step 204 the level of carbon dioxide 18 in an individual is measured.This level can be measured using one of the various processes listedabove. The measured level of carbon dioxide 18 is preferably expressedin the same units of measurement as that used in the measurement ofoxygen 16 so as to more readily compare the levels with respect to eachother in order to obtain a base level. This level can be expressed bythe variable Y. There is a preferred range in which Y may fall thatvaries depending upon the type of test that is used in order to measurethe level of carbon dioxide 18. In an embodiment of the presentinvention a standard type of test is used.

In step 206 the level of nitric oxide 10 in an individual is measured.This level can be measured using one of the various processes listedabove. The measured level of nitric oxide 10 is preferably expressed inthe same units of measurement as that used in the measurement of oxygen16 so as to more readily compare the levels with respect to each otherin order to obtain a base level. This level can be expressed by thevariable Z. There is a preferred range in which Z may fall that variesdepending upon the type of test that is used in order to measure thelevel of nitric oxide 10. In an embodiment of the present invention astandard type of test is used.

In step 208, the measured levels X, Y and Z are then compared tostandard levels. This may be done in a number of different ways. Onepossible way in which this can be accomplished is to total the values ofall of the levels (X+Y+Z) in order to establish sum level C. This sumlevel C can be used in step 210 in order to establish a treatment of theindividual that can be used in determining the provision of medicationand other matters related to the measured levels.

The treatment may include, but is not limited to the provision of morenitric oxide 10 to an individual. Alternatively, the reduction of nitricoxide 10 may be necessitated. The provision of and/or reduction ofcarbon dioxide 18 and/or oxygen 16 may also be part of the treatment inorder to return the levels of nitric oxide 10, oxygen 16 and carbondioxide 18 to normal levels.

An example of this is provided below using hypothetical numbers to makeunderstanding of the process easier.

Measuring oxygen 16 via a blood test results in a number for X thatresults in a number 4, from within a range of 1-10. Measuring carbonmonoxide 18 via a blood test results in a number for Y of 5 from withina range of 1-10. Measuring nitric oxide 10 via a blood test results in anumber for Z of 7 from within a range of between 1-10. These numbers arethen totaled and results in a C value of 16. A value for C between 12and 18 may indicate a normal level.

The assessment of the modulated pairs of gases enables the provision ofconsulting/counseling services relative to the biological foundation forand between the gases and neurohormones associated with logic/decisionmaking and emotions for the purpose of enhancing or remediatingintellect or behavioral outcomes for children, students, employees andpatients.

The assessment of the modulated pairs of gases may be used to providetraining counselors or other personnel associated with the care ortreatment of individuals who are experiencing disruptions in thoughtprocesses (including but not limited to Asperger's, ADHD, ADD, dementia,forms of over focus, etc.) as well as emotional disruptions (includingbut not limited to Obsessive-Compulsive Disorder (OCD), OppositionalDefiant Disorder (ODD), Post Traumatic Stress Disorder (PTSD), anddepression). These training methods will include the use of graphicillustrations; computer generated information, printed and videomaterial, as well as verbal instructional information pertaining to thehomeostasis or relationship of or between neurohormones in pairs as wellas in modulated pairs.

The assessment of the modulated pairs of gases may also be used forcreating a baseline assessment of an individual's homeostatic levels ofactivity within modulated pairs of gases for the purpose of establishinga foundation from which prevention of illnesses, treatment regimens oreducational planning can be optimized.

The assessment of the modulated pairs of gases may also be used for themanufacture, sale, or use of devices for the purpose of reconfiguringgases or adjusting levels for the purpose of modifying behavior orimproving mental health as well as for use in NeurohormoneReconfiguration^(SM) or as part of neuroplasticity when treatingpatients with cognitive or emotional disorders due to injury or illness.

The assessment of the modulated pairs of gases may also be used for themanufacture, sale or use of devices to monitor MFA or to be used inconjunction with processes intended to perform ReflectiveMeditation^(SM).

The assessment of the modulated pairs of gases may also be used for themanufacture, sale or use of devices to measure MFA as a means ofassessing intellectual capabilities, such as IQ.

The assessment of the modulated pairs of gases may also be used for themanufacture, sale or use of devices to assess biometric indicators todetermine absorption rate of cells as a means of assessingsusceptibility for illnesses or sensitivity to foods, herbs, medicationsor environmental irritants and potential toxins.

The assessment of the modulated pairs of gases may also be used for themanufacture, sale or use of devices to create or assess biometricindicators to determine possible causes of lupus, cancer and otherchronic diseases and also be used as a tool to assist with processes toreduce MFA as part of treatment regimens.

The assessment of the modulated pairs of gases may also be used forenabling diagnostic assessment of values of gases in relation to otherswithin a modulated pair or between modulated pairs.

The assessment of the modulated pairs of gases may also be used forassessing the impact of various substances on the modulated pairsresponsible for the firing rate of neurons and signaling mechanisms andtheir impact on the body's rates of activities will enable scientistsand medical professionals to diagnose root causes of diseases anddisorders. This aspect of the invention can enable evaluation of theimpact of disruptions from imbalances in amino acid neurotransmitters orcellular adhesion that may cause hormone, organ or gland imbalances.Assessment of these processes can prevent diseases or enable treatmentregimens for diabetes, obesity resulting from disruptions for when tostore fat, thyroid imbalances as well as numerous other diseaseentities.

The assessment of the modulated pairs of gases may also be used for theassessment (diagnostic testing) of the impact on the relationship ofgases within modulated pairs by any substances ingested or absorbed bythe body relative to neural firing rates (i.e. aspartate—gammaaminobutyric acid—glutamate).

The assessment of the modulated pairs of gases may also be used for theassessment of neurohormone levels to gauge intellectual capacity orcapabilities (e.g. IQ).

The assessment of the modulated pairs of gases may also be used as atool for assessment of or modification to thought patterns or behaviorin business applications by trained specialists in categorization ofbehavioral characteristics, consultants, management personnel includingexecutives or educational personnel associated with employee training ororganizational development processes. These processes can be forindividuals, groups such as teams or work units as well as entirecorporations or portions thereof.

The assessment of the modulated pairs of gases may also be used for theapplication of the tenets of neurobiology (i.e. NeurohormoneReconfiguration^(SM), modification to neural architecture through neuralplasticity or alteration of neural firing rates) as the concept appliesto the modification or creation of cultures in business (including butnot limited to healthcare), academia or scientific research.

The assessment of the modulated pairs of gases may also be used forpublishing of information and provision of consulting, counseling oreducational services relative to the biological foundation for andbetween the gases associated with logic/decision making and emotions forthe purpose of enhancing or remediating intellect for behavioraloutcomes for children, students, employees and patients.

The assessment of the modulated pairs of gases may also be used incounseling, coaching, consulting and other services provided as part ofpersonalized (precision—explicit) medicine or other services provided aspart of spa treatments or related activities associated with wellness orpreventative, or therapeutic treatments.

The assessment of the modulated pairs of gases may also be used forforms of testing or assessment of gas levels or disruptions to modulatedpairs to ascertain the existence of Hormone Induced Detachment^(SM)(“burnout”), Asperger's, ADHD, ADD, dementia, forms of over focus, etc.)as well as emotional disruptions (including but not limited toObsessive-Compulsive Disorder (OCD), Oppositional Defiant Disorder(ODD), Post Traumatic Stress Disorder (PTSD), and depression).

The assessment of the modulated pairs of gases may also be used forclinical and other counseling and treatment programs as well ascommunities of practice (e.g. Weight Watchers, Alcoholics Anonymous, andservices for Obsessive-Compulsive Disorders and addictions; includingbut not limited to smoke cessation, dieting, and substance abuse thatincorporate education and training relative to modulated pairs of gases,assessment of neural firing rates (i.e. mental functioning activity—MFA)and the ability to reconfigure the wiring in the brain through theprocess of Neurohormone Reconfiguration^(SM) or the process ofReflective Meditation^(SM).

The usage of these methods can also be used with devices that willmeasure levels of the gases contained within the body that include thoselisted in the invention and assess the corollary relationships betweenthese gases in order to compare them to standard biodiagnostic baselineassessment.

The usage of these methods can also be used with devices that measurethe levels of the gases listed in the invention that are in theenvironment, such as the air, and assess the corollary relationshipsbetween these gases in order to compare them to standards establishedfor proper air quality.

The usage of these methods can also be used with devices that measurethe levels of the gases listed in the invention that are in water,inland as well as seas and oceans and stored for use in air conditioningand drinking purposes, and assess the corollary relationships betweenthese gases in order to compare them to standards established for properwater quality.

The usage of these methods can also be used for medications(prescription and over the counter) and herbal preparations that can beprepared to correct imbalances between normal values that areestablished for the substances that comprise the modulated pairs ofsubstances listed in this invention.

The usage of these methods can also be used for assessment ofhomeostatic imbalances of relationships within modulated pairs that canenable therapies to correct these disruptions instead of waiting to thepoint where mental or physical consequences will require expensive orsophisticated treatment of ailments or diseases that are the outcomes.

The usage of these methods can also be used to ascertain disruptions ofthe base values of the relationships within the modulated pairs of thesubstances listed in this invention that can have various negativeimpacts throughout the body and the brain. Diseases and disorders thatcan be directly attributable to multiple concurrent disruptions ofhomeostasis established with modulated pairs can include but are not belimited to various types of cancers, Parkinson's, Asperger's,Alzheimer's, end stage renal disease, obstructive sleep apnea, insomnia,diabetes, obesity as well as the diseases associated with the formationof and processes associated with connective tissue and smooth musclethat comprises veins, arteries, organs and glands, etc.

Assessment of the impact of various substances on the modulated pairsresponsible for the firing rate of neurons and signaling mechanisms andtheir impact on the body's rates of activities enable scientists andmedical professionals to diagnose root causes of diseases and disorders.This aspect of the invention can enable evaluation of the impact ofdisruptions from imbalances in gasotransmitters (gases that arecontained within the body that function as components of signalingmolecules) that maintain mechanisms that may cause DNA, RNA, nucleotide,hormone, organ or gland imbalances. Assessment of these processes canprevent diseases or enable treatment regimens for cardiovasculardiseases, obstructive sleep apnea, prevention or treatment of parasiticdiseases, and the degree of flexibility of the body's skin, veins,arteries and organs as well as numerous other disease entities.

The usage of these methods can also be used for the design of devices tocorrelate the relationship between the various gases contained in thebody as listed in this invention. These devices can include but shouldnot be limited to ones used within the veins and arteries, ongoingassessment as implanted devices, monitoring devices for home use orthose used to perform diagnostic assessments in physicians' offices,hospitals, diagnostic laboratories, home care or any other setting wherethe analysis of these gases contained in the blood are measured andcompared to each other to perform assessments to maintain proper healthand well being. A schematic of the system diagram is shown in FIG. 7.

FIG. 7 shows a personalized report generator system 700 designed andarranged in accordance with an embodiment of the present invention. Itshould be understood that the system 700 shows the basic components ofthe system and that more or less individualized components may beprovided. FIG. 8 is a flow chart showing the steps involved in using thesystem 700.

The personalized report generator system 700 comprises a database 710 inwhich may be stored various test results, which are stored in thedatabase 710 as test data 720. The test data 720 is in a format that iscapable of being manipulated by computers, processors, etc. The testdata 720 may comprise various gas levels. In an exemplary embodiment ofthe present invention and shown in step 302, tests are performed onindividual patients. In step 304, the results of these tests are thenreduced into an electronic format in order to produce the test data 720.For example, the database 710 may store blood test data 722, mouth swabdata 724 and breath analysis data 726. Other tests may include urine;fecal matter; collagen; chyle; interstitial fluid (tissue fluid); lymph;extracellular fluid; amniotic fluid; sweat tears; saliva; mucus; phlegm;hair; fingernails; and bone marrow. Each of these various tests mayscreen for a plurality of gases. As an example, the breath analysis data726 may screen for nitric oxide, carbon dioxide or hydrogen sulfide.Performing a breath analysis may done using testing kits that test for aspecific gas, such as nitric oxide, or done via analysis in a labsetting. More than one kit may used for each gas tested for.

The test data 720 may be organized and stored at the database 710.Alternatively, satellite locations may each maintain their own databases710 that control their own records. In step 306, these locations may beaccessed periodically by the central server 730 or the various databases710 may transmit their results to a central location that is thenaccessible by a central server 730. Preferably the test data 720 is onlyaccessed or transmitted when a certain threshold number of results areobtained. For example the test data 720 may not be sent to the centralserver 730 until at least one hundred tests are prepared to betransmitted.

In step 308, the transmitted test data 720 is compiled and stored ascompiled test data 741. The central server 730 may keep the sent oraccessed compiled test data 741 stored at its location in the centraldatabase 740, or the system 700 may provide a distributed storage systemthat stores the compiled test data 741 at external locations as well asthe central database 740. However it should be understood that whencompiled test data 741 is stored at distributed sites the system stillfunctions as if they were stored at the central database 740. Thecompiled test data 741, may be stored so that the origin of the data ismaintained in an anonymous fashion. In some instances tracking of theorigin of a test result may only occur when a personalized report isrequested.

In step 310, the compiled test data 741 is then analyzed in order todetermine significant figures for conducting analysis. The analysis maybe accomplished with the usage of a computer(s) 725 of which the server730 may be a part of, as well as the database 710. The analysis may beaccomplished by statistically compiling and correlating the results forone specific test or by compiling the data for two separate items thatare believed to have a relationship. Specific values from the pluralityof compiled test data 741 having a similar feature may be analyzed. Thismay be accomplished through the application of known statisticalalgorithms. In step 312, the statistically compiled test data 741 may beused to form the correlated data 742. In step 314, the statisticallycorrelated data 742 are then used by the individual report generator 743to form the personalized medical prescription and diagnosis. Uponreceipt of individual test data 751 from a client computer 750, theindividual report generator 743 processes the data and transmits anindividual report 752 to a client computer 750.

The compiled test data 741 may be periodically updated from thedatabases 710 and through the addition of more collected test data. Theupdating of the compiled test data 741 may provide additionalinformation with which to refine the correlated data 742 and to refinethe ranges used by the individual report generator 743 when producingthe personalized medical prescription and diagnosis. Additionally theupdating of the compiled test data 741 may be a continuous featurewherein the addition of new information is immediately reflected in thecorrelated data 742. This may provide for a constantly fluid analysis ofcompiled test data 741 that may reflect changes in population and dietsin society.

The usage of these methods can also be used for the design of devices tocorrelate the relationship between the various gases contained in theenvironment (air) as listed in this invention. These devices can includebut should not be limited to ones used within homes, publictransportation, the workplace (buildings), stores and other commercialbuilding or places where people gather as well as for general monitoringof air quality as established in the future. A schematic of the systemdiagram is shown in FIG. 9.

FIG. 9 shows a report generator system 900 designed and arranged inaccordance with an embodiment of the present invention. It should beunderstood that the system 900 shows the basic components of the systemand that more or less individualized components may be provided. FIG. 10is a flow chart showing the steps involved in using the system 900.

The report generator system 900 comprises a database 910 in which may bestored various test results, which are stored in the database 910 astest data 920. The test data 920 is in a format that is capable of beingmanipulated by computers, processors, etc. The test data 920 maycomprise various gas levels. In an exemplary embodiment of the presentinvention and shown in step 402, tests are performed on gaseousenvironments, such as the atmosphere, a room's environment, etc. In step404, the results of these tests are then reduced into an electronicformat in order to produce the test data 920. For example, the database910 may store air test data 922.

Each of these tests may screen for a plurality of physical compoundlevels of different gases. As an example, air test data 922 may screenfor oxygen, nitric oxide, carbon dioxide, carbon monoxide or hydrogensulfide. Testing may be performed using standard testing devices andanalysis kits. For example, mass spectrometry of samples taken fromwater to be tested may be tested using kits such as that described inU.S. Pat. No. 5,101,671. Air samples may be collected on site and sentto a lab for analysis. Alternatively, samples may be collected and testsfor targeted gases may be performed on site.

The test data 920 may be organized and stored at the database 910.Alternatively, satellite locations may each maintain their own databases910 that control their own records. In step 406, these locations may beaccessed periodically by the central server 930 or the various databases910 may transmit their results to a central location that is thenaccessible by a central server 930. Preferably the test data 920 is onlyaccessed or transmitted when a certain threshold number of results areobtained. For example the test data 920 may not be sent to the centralserver 930 until at least one hundred tests are prepared to betransmitted.

In step 408, the transmitted test data 920 is compiled and stored ascompiled test data 941. The central server 930 may keep the sent oraccessed compiled test data 941 stored at its location in the centraldatabase 940, or the system 900 may provide a distributed storage systemthat stores the compiled test data 941 at external locations as well asthe central database 940. However, it should be understood that whencompiled test data 941 is stored at distributed sites the system stillfunctions as if they were stored at the central database 940. Thecompiled test data 941 may be stored so that the origin of the data ismaintained in an anonymous fashion. In some instances tracking of theorigin of a test result may only occur when a personalized report isrequested.

In step 410, the compiled test data 941 is then analyzed in order todetermine significant figures for conducting analysis. The analysis maybe accomplished with the usage of a computer(s) 925 of which the server930 may be a part of, as well as the database 910. The analysis may beaccomplished by statistically compiling and correlating the results forone specific test or by compiling the data for two separate items thatare believed to have a relationship. Specific values from the pluralityof compiled test data 941 having a similar feature may be analyzed. Thismay be accomplished through the application of known statisticalalgorithms. In step 412, the statistically compiled test data 941 may beused to form the correlated data 942. In step 414, the statisticallycorrelated data 942 is then used by the report generator 943 to form thepersonalized medical prescription and diagnosis. Upon receipt ofindividual test data 951 from a client computer 950, the reportgenerator 943 processes the data and transmits an individual report 952to a client computer 950.

The compiled test data 941 may be periodically updated from thedatabases 910 and through the addition of more collected test data. Theupdating of the compiled test data 941 may provide additionalinformation with which to refine the correlated data 942 and to refinethe ranges used by the report generator 943 when producing the resultsof the analysis. Additionally the updating of the compiled test data 941may be a continuous feature wherein the addition of new information isimmediately reflected in the correlated data 942. This may provide for aconstantly fluid analysis of compiled test data 941 that may reflectchanges in the environment.

Treatment may involve the employment of devices for scrubbing variousgases from the atmosphere of a given environment. For example, if theenvironment was a particular room or building, filters or air purifiersdesigned to filter out specific gases may be employed in order to returna select environment to homeostatic balance. This may also involveadding select gases to the environment instead of reducing levels of aselect gas.

The usage of these methods can also be used for the design of devices tocorrelate the relationship between various gases contained in water. Thelocation of this water includes but is not limited to inland streams,rivers, ponds and lakes; seas and oceans as well as in water treatmenttowers associated with air conditioning and water storage forconsumption by humans and animals and assess the corollary relationshipsbetween these gases in order to compare them to standards establish forproper water quality. A schematic of the system diagram is shown in FIG.11.

FIG. 11 shows a report generator system 1100 designed and arranged inaccordance with an embodiment of the present invention. It should beunderstood that the system 1100 shows the basic components of the systemand that more or less individualized components may be provided. FIG. 12is a flow chart showing the steps involved in using the system 1100.

The report generator system 1100 comprises a database 1110 in which maybe stored various test results, which are stored in the database 1110 astest data 1120. The test data 1120 is in a format that is capable ofbeing manipulated by computers, processors, etc. The test data 1120 maycomprise various gas levels. In an exemplary embodiment of the presentinvention and shown in step 502, tests are performed on gaseousenvironments, such as the atmosphere, a room's environment, etc. In step504, the results of these tests are then reduced into an electronicformat in order to produce the test data 1120. For example, the database1110 may store water test data 1122.

Each of these tests may screen for a plurality of physical compoundlevels of different gases. As an example, water test data 1122 mayscreen for oxygen, nitric oxide, carbon dioxide, carbon monoxide orhydrogen sulfide. Testing may be performed using standard water testingdevices and analysis kits. For example, mass spectrometry of samplestaken from water to be tested may be used.

The test data 1120 may be organized and stored at the database 1110.Alternatively, satellite locations may each maintain their own databases1110 that control their own records. In step 506, these locations may beaccessed periodically by the central server 1130 or the variousdatabases 1110 may transmit their results to a central location that isthen accessible by a central server 1130. Preferably the test data 1120is only accessed or transmitted when a certain threshold number ofresults are obtained. For example the test data 1120 may not be sent tothe central server 1130 until at least one hundred tests are prepared tobe transmitted.

In step 508, the transmitted test data 1120 is compiled and stored ascompiled test data 1141. The central server 1130 may keep the sent oraccessed compiled test data 1141 stored at its location in the centraldatabase 1140, or the system 1100 may provide a distributed storagesystem that stores the compiled test data 1141 at external locations aswell as the central database 1140. However, it should be understood thatwhen compiled test data 1141 is stored at distributed sites the systemstill functions as if they were stored at the central database 1140. Thecompiled test data 1141 may be stored so that the origin of the data ismaintained in an anonymous fashion. In some instances tracking of theorigin of a test result may only occur when a personalized report isrequested.

In step 510, the compiled test data 1141 is then analyzed in order todetermine significant figures for conducting analysis. The analysis maybe accomplished with the usage of a computer(s) 1125 of which the server1130 may be a part of, as well as the database 1110. The analysis may beaccomplished by statistically compiling and correlating the results forone specific test or by compiling the data for two separate items thatare believed to have a relationship. Specific values from the pluralityof compiled test data 1141 having a similar feature may be analyzed.This may be accomplished through the application of known statisticalalgorithms. In step 512, the statistically compiled test data 1141 maybe used to form the correlated data 1142. In step 514, the statisticallycorrelated data 1142 is then used by the report generator 1143 to formthe personalized medical prescription and diagnosis. Upon receipt ofindividual test data 1151 from a client computer 1150, the reportgenerator 1143 processes the data and transmits an individual report1152 to a client computer 1150.

The compiled test data 1141 may be periodically updated from thedatabases 1110 and through the addition of more collected test data. Theupdating of the compiled test data 1141 may provide additionalinformation with which to refine the correlated data 1142 and to refinethe ranges used by the report generator 1143 when producing the resultsof the analysis. Additionally the updating of the compiled test data1141 may be a continuous feature wherein the addition of new informationis immediately reflected in the correlated data 1142. This may providefor a constantly fluid analysis of compiled test data 1141 that mayreflect changes water content.

Treatment may involve the employment of devices for scrubbing variousgases from the water. For example, if the environment was a stream,filters may be employed to filter out specific gases in order to returnthe water to homeostatic balance. This may also involve adding selectgases to the water instead of reducing levels of a select gas.

It is to be understood, however, that even though numerouscharacteristics and advantages of the present invention have been setforth in the foregoing description, together with details of thestructure and function of the invention, the disclosure is illustrativeonly, and changes may be made in detail, especially in matters of shape,size and arrangement of parts within the principles of the invention tothe full extent indicated by the broad general meaning of the terms inwhich the appended claims are expressed.

What is claimed is:
 1. A method for treating an individual by comparing levels of gases in an individual: measuring a level of nitric oxide in the individual; measuring a level of carbon monoxide in the individual; measuring a level of hydrogen sulfide in the individual; comparing the measured levels; and establishing a treatment based upon the compared measured levels.
 2. The method of claim 1, wherein the step of measuring a level of nitric oxide comprises using means for measuring a level of nitric oxide in the individual; wherein the step of measuring carbon monoxide in the individual comprises using means for measuring a level of carbon monoxide in the individual; wherein the step of measuring hydrogen sulfide in the individual comprises using means for measuring a level of hydrogen sulfide in the individual; and wherein the step of comparing comprises using means for comparing.
 3. The method of claim 2, wherein the means for measuring a level of carbon monoxide is a breath analysis device.
 4. The method of claim 1, further comprising measuring a level of oxygen in the individual; and measuring a level of carbon dioxide in the individual.
 5. The method of claim 1, wherein the treatment comprises reducing intake of nitric oxide.
 6. The method of claim 1, wherein test data is stored in a central computer and compiled.
 7. The method of claim 1, wherein the levels of nitric oxide, carbon monoxide and hydrogen sulfide are re-measured.
 8. A method for establishing a treatment by comparing levels of gases in an environment: measuring a level of nitric oxide in the environment; measuring a level of carbon monoxide in the environment; measuring a level of hydrogen sulfide in the environment; comparing the measured levels; and establishing a treatment based upon the compared measured levels.
 9. The method of claim 8, wherein the step of measuring a level of nitric oxide comprises using means for measuring a level of nitric oxide in the environment; wherein the step of measuring carbon monoxide comprises using means for measuring a level of carbon monoxide in the environment; wherein the step of measuring hydrogen sulfide comprises using means for measuring a level of hydrogen sulfide in the environment; wherein the step of comparing comprises using means for comparing the measured levels.
 10. The method of claim 9, wherein the means for measuring a level of carbon monoxide is a device for testing the atmosphere.
 11. The method of claim 8, further comprising measuring a level of oxygen in the environment; and measuring a level of carbon dioxide in the environment.
 12. The method of claim 8, wherein the treatment comprises reducing nitric oxide in the environment.
 13. The method of claim 8, wherein the treatment comprises reducing carbon monoxide in the environment.
 14. The method of claim 8, wherein the treatment comprises reducing nitric oxide in the water.
 15. The method of claim 8, wherein the treatment comprises reducing carbon monoxide in the water. 